TB combination drug: an interview with Mel Spigelman, MD, CEO and President of TB Alliance – News-Medical.Net

The traditional definition of MDR-TB is resistance to two of the first-line drugs, isoniazid and rifampin. Because this treatment does not include those drugs, this regimen could potentially be used for treating both drug-sensitive and drug …

Powered by WPeMatico